Showing results (151-160 of 196) with videos related to
Sort By:
Pageof 20
Cancer Genetics|December 2, 2019
Longitudinal whole-genome sequencing reveals the evolution of MPALYu Zhang, Zhijie Kang, Dekang Lv, et al.Oncotarget|February 18, 2015
Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancerDong-Ge Niu, Fei Peng, Wei Zhang, et al.Cancer Research|November 3, 2007
Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cellsZhong Guan, Xian-ren Wang, Xiao-feng Zhu, et al.Molecular Cancer|September 7, 2020
Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit GliomagenesisJiacheng Lou, Yuchao Hao, Kefeng Lin, et al.Nature Medicine|January 2, 2018
Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphomaHaijun Wen, Huajuan Ma, Qichun Cai, et al.Oncology Reports|July 15, 2014
Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancerMin Dong, Xin-Juan Fan, Zhan-Hong Chen, et al.Oncotarget|March 27, 2015
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cellsZhi-Jie Hou, Xi Luo, Wei Zhang, et al.Cell Communication and Signaling : CCS|July 25, 2024
Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stressJinxin Lu, Xiaoyu Zhang, Keyu Su, et al.Cancer Cell International|August 27, 2021
Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)Aisha Al-Dherasi, Yuwei Liao, Sultan Al-Mosaib, et al.Medical Oncology (Northwood, London, England)|February 15, 2013
Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancerMin Dong, Xiang-bo Wan, Zhong Yu Yuan, et al.Pageof 20